Home1NE • FRA
Verrica Pharmaceuticals Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 3.44M | -10.12% |
Operating expense | 8.85M | -45.85% |
Net income | -9.74M | 52.08% |
Net profit margin | -283.28 | 46.69% |
Earnings per share | -0.10 | 77.27% |
EBITDA | -7.99M | 56.40% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 29.60M | -39.53% |
Total assets | 42.18M | -36.39% |
Total liabilities | 60.75M | -6.24% |
Total equity | -18.58M | — |
Shares outstanding | 92.49M | — |
Price to book | -2.65 | — |
Return on assets | -42.21% | — |
Return on capital | -67.82% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -9.74M | 52.08% |
Cash from operations | -12.68M | 36.45% |
Cash from investing | — | — |
Cash from financing | -4.06M | -513.77% |
Net change in cash | -16.73M | 18.80% |
Free cash flow | -9.73M | 25.61% |
Previous close
€0.53
Day range
€0.50 - €0.50
Year range
€0.32 - €8.27
Market cap
52.99M USD
Avg Volume
293.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2013
Headquarters
Website
Employees
71
